OTC · Financial Statements
Aridis Pharmaceuticals, Inc. (ARDS) Financial Statements
$0.00
OTC: ARDS
Market Cap $4457
Overview Financials Dividend Aridis Pharmaceuticals, Inc. most recently reported annual revenue of $0, net profit of $-31.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $3.0M $1.0M $1.0M $0 $0 Operating Profit $-24.0M $-29.0M $-22.0M $-44.0M $-30.0M Net Profit $-22.0M $-30.0M $-22.0M $-42.0M $-31.0M EPS $-7.02 $-3.43 $-2.44 $-3.44 $-1.64 Op Margin -874.8% -2846.1% -2240.1% — —
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $32.0M $28.0M $15.0M $27.0M $15.0M Total Liabilities $5.0M $24.0M $24.0M $41.0M $39.0M Cash $24.0M $21.0M $8.0M $20.0M $5.0M Borrowings $0 $0 $1.0M $6.0M $6.0M
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-24.0M $-8.0M $-20.0M $-23.0M $-29.0M Investing Cash Flow $-2.0M $0 $-1.0M $-1.0M $0 Financing Cash Flow $1.0M $0 $0 $4.0M $-1.0M Net Cash Flow $-1.0M $-3.0M $-12.0M $11.0M $-14.0M Free Cash Flow $-25.0M $-8.0M $-21.0M $-23.0M $-29.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.04 FCF Yield -655351.13% Quick Ratio 0.32 Interest Coverage -79.35 Return 1Y 0.00% Return 3Y -99.96% Return 5Y —
Screens featuring this stock